Abivax (ABVX) Invested Capital (2021 - 2025)
Abivax (ABVX) posted quarterly Invested Capital of $37.4 million for Q4 2025, down 69.33% year-over-year from $121.8 million in Q4 2024, and down 56.81% quarter-over-quarter from $86.5 million in Q3 2025.
Abivax (ABVX) Invested Capital (2021 - 2025) Analysis & Trends
Abivax's Invested Capital history runs 5 years deep, the most recent figure standing at $37.4 million for Q4 2025.
- In Q4 2025, Invested Capital fell 69.33% year-over-year to $37.4 million; the TTM figure through Mar 2026 stood at $241.5 million (changed 0.08% YoY), while the FY2025 annual figure was $37.4 million, down 69.33% from the prior year.
- Invested Capital for Q4 2025 stood at $37.4 million, down from $86.5 million in the prior quarter.
- The five-year high for Invested Capital was $121.8 million in Q4 2024, with the low at $2.7 million in Q2 2024.
- The 5-year median for Invested Capital is $82.9 million (2023), against an average of $76.4 million.
- Peak annual rise in Invested Capital reached 4303.98% in 2025, while the deepest fall reached 69.33% in 2025.
- Abivax's Invested Capital stood at $70.5 million in 2021, then decreased by 27.89% to $50.8 million in 2022, then soared by 63.16% to $82.9 million in 2023, then soared by 46.96% to $121.8 million in 2024, then sank by 69.33% to $37.4 million in 2025.
- Business Quant data shows ABVX's Invested Capital at $37.4 million in Q4 2025, $86.5 million in Q3 2025, and $117.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.36 Mn |
| Sep 30, 2025 | 86.50 Mn |
| Jun 30, 2025 | 117.62 Mn |
| Mar 31, 2025 | 117.16 Mn |
| Dec 31, 2024 | 121.82 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Dec 31, 2023 | 82.90 Mn |
| Dec 31, 2022 | 50.81 Mn |
| Dec 31, 2021 | 70.45 Mn |